SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-12
acquisitionAnnounced · Mar 6, 2026BiopharmaceuticalsSource · CredibleArticle · Factual
Servier acquires Day One Biopharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.5B
Target
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Full Acquisition
Status
Pending
Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: Biopharmaceuticals. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.
Shares of Day One Biopharmaceuticals , Inc. are surging about 65 percent on Friday morning trading after Servier , an independent international pharmaceutical group, agreed to acquire the company for $21.50 per share in cash
Deal timeline
Announced
Mar 6, 2026 · nasdaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biopharmaceuticals with a reported deal value of $2.5B. Figures and status may change as sources update.
Sources: nasdaq.com · Primary article · FireStrike proprietary index